Primary |
Product Used For Unknown Indication |
25.8% |
Drug Use For Unknown Indication |
21.3% |
Nasopharyngitis |
11.9% |
Intentional Overdose |
7.6% |
Upper Respiratory Tract Infection |
7.6% |
Cough |
7.0% |
Suicide Attempt |
6.7% |
Ill-defined Disorder |
2.7% |
Nasal Congestion |
2.4% |
Injury |
1.5% |
Influenza |
1.2% |
Child Abuse |
0.6% |
Immunisation |
0.6% |
Infection |
0.6% |
Skin Test |
0.6% |
Skin Test Positive |
0.6% |
Candidiasis |
0.3% |
Cardiac Disorder |
0.3% |
Dermatitis Diaper |
0.3% |
Hypercholesterolaemia |
0.3% |
|
Drug Toxicity |
15.3% |
Sudden Infant Death Syndrome |
11.5% |
Wrong Drug Administered |
9.9% |
Unresponsive To Stimuli |
8.4% |
Vomiting |
8.4% |
Death |
6.9% |
Overdose |
4.6% |
Pneumonia Viral |
3.8% |
Toxicity To Various Agents |
3.8% |
Loss Of Consciousness |
3.1% |
Paraesthesia |
3.1% |
Pneumonia |
3.1% |
Tachycardia |
3.1% |
Cardio-respiratory Arrest |
2.3% |
Drug Screen Positive |
2.3% |
Oedema |
2.3% |
Pulmonary Oedema |
2.3% |
Tibia Fracture |
2.3% |
Urinary Retention |
2.3% |
Anoxic Encephalopathy |
1.5% |
|
Secondary |
Drug Use For Unknown Indication |
36.9% |
Product Used For Unknown Indication |
25.1% |
Nasopharyngitis |
8.7% |
Intentional Overdose |
5.2% |
Suicide Attempt |
4.7% |
Pain |
2.8% |
Upper Respiratory Tract Infection |
2.5% |
Cough |
2.4% |
Nasal Congestion |
2.3% |
Ill-defined Disorder |
1.8% |
Influenza |
1.5% |
Depression |
1.0% |
Hepatitis C |
0.8% |
Insomnia |
0.8% |
Pyrexia |
0.8% |
Seasonal Allergy |
0.8% |
Pharyngitis |
0.5% |
Skin Test |
0.5% |
Skin Test Positive |
0.5% |
Asthma |
0.4% |
|
Completed Suicide |
21.3% |
Death |
10.7% |
Drug Toxicity |
9.3% |
Respiratory Arrest |
6.7% |
Sudden Infant Death Syndrome |
6.0% |
Toxicity To Various Agents |
5.3% |
Pyrexia |
4.7% |
Intentional Overdose |
4.0% |
Drug Hypersensitivity |
3.3% |
Pulmonary Congestion |
3.3% |
Unresponsive To Stimuli |
3.3% |
Cardio-respiratory Arrest |
2.7% |
Pneumonia |
2.7% |
Shock |
2.7% |
Tremor |
2.7% |
Urinary Retention |
2.7% |
Victim Of Homicide |
2.7% |
Cardiac Arrest |
2.0% |
Diarrhoea |
2.0% |
Drug Screen Positive |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
21.8% |
Drug Use For Unknown Indication |
20.6% |
Acute Lymphocytic Leukaemia |
7.4% |
Depression |
7.3% |
Pain |
4.8% |
Asthma |
4.6% |
Hiv Infection |
4.1% |
Influenza |
3.4% |
Gastrooesophageal Reflux Disease |
3.0% |
Insomnia |
2.7% |
Sleep Disorder |
2.5% |
Anxiety |
2.3% |
Hypertension |
2.3% |
Multiple Allergies |
2.3% |
Arthralgia |
1.9% |
Muscle Spasms |
1.9% |
Nausea |
1.9% |
Post-traumatic Stress Disorder |
1.9% |
Arthritis |
1.8% |
Libido Decreased |
1.7% |
|
Weight Decreased |
10.1% |
Weight Increased |
9.2% |
Pulmonary Embolism |
8.4% |
Nausea |
5.9% |
Urinary Retention |
5.9% |
Electrocardiogram Qt Prolonged |
5.0% |
Off Label Use |
5.0% |
Vomiting |
5.0% |
White Blood Cell Count Increased |
5.0% |
Death |
4.2% |
Respiratory Failure |
4.2% |
Urinary Incontinence |
4.2% |
Ventricular Tachycardia |
4.2% |
Anxiety |
3.4% |
Palpitations |
3.4% |
Pneumonia |
3.4% |
Pyrexia |
3.4% |
Sinusitis |
3.4% |
Suicide Attempt |
3.4% |
Treatment Noncompliance |
3.4% |
|
Interacting |
Attention Deficit/hyperactivity Disorder |
40.0% |
Drug Use For Unknown Indication |
40.0% |
Anxiety |
20.0% |
|
Hallucination |
66.7% |
Drug Interaction |
33.3% |
|